The Application of Rapid Fresh Digital Pathology on the Diagnosis and Biomarker Testing of Lung Cancer
NCT06497686 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2024-07-15
Summary
Through this project, the rapid staining process will be optimized for ex-vivo human lung specimens and integrate advanced ex-vivo mesoscale nonlinear optical gigascope. Initially, this will provide rapid digital pathological diagnosis during lung cancer surgeries. This will help achieve the dual goals of precise and efficient complete resection of lung cancer tissues while preserving tissue functionality. The application of this technology aims to provide higher-quality medical services for patients suffered from lung cancers.
Conditions
- Lung Cancer
- Intraoperative Pathology
- 3D Pathology
- Immunochemistry Staining
Interventions
- DIAGNOSTIC_TEST
-
mesoscale nonlinear optical gigascope
An nonlinear optical microscope with ultra-large field of view and ultra-high resolution.
- DIAGNOSTIC_TEST
-
Fluorescence microscope
An optical microscope used to examine the fluorescence signal from stained tissues.
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-07-15
- Primary Completion
- 2025-06-30
- Completion
- 2025-12-31
More Related Trials
-
Development and Clinical Validation of Early-stage Lung Cancer Prognostic Kit
NCT05557474 ·Status: RECRUITING
-
Validation of High-Throughput Large-Format Tissue Preprocessing for Lung and Colorectal Cancer
NCT07239063 ·Status: RECRUITING
-
Real-Time Optical Biopsy in Improving Lung Cancer Diagnosis in Patients Undergoing Lung Biopsy
NCT03376971 ·Status: COMPLETED ·Phase: NA
-
Established Lung Cancer Cell Line and Stroma Cell From Surgical Tissue
NCT01058811 ·Status: UNKNOWN
-
Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer
NCT04156360 ·Status: UNKNOWN
-
Feasibility of Intratumoral Washing Fluid for Detecting EGFR Mutations in Lung Cancer
NCT05517083 ·Status: COMPLETED ·Phase: NA
-
Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery
NCT05648370 ·Status: UNKNOWN
-
Thin Prep Versus Traditional Cytological Procedure for Lung Cancer
NCT02007538 ·Status: COMPLETED
-
DNA Repair Genes and Outcomes in Patients With Stage III NSCLC
NCT00797238 ·Status: UNKNOWN
-
The Feasibility of Dynamic Liquid Biopsy Monitoring During Neoadjuvant Treatment for EGFR-mutated NSCLC
NCT06287593 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
MRD Monitoring in Lung Cancer After Resection
NCT04976296 ·Status: RECRUITING
-
EB-OCT Biopsy Guidance of Lung Cancer
NCT06556680 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Epigenetic Nucleosomes in Plasma for Pulmonary Nodule Differentiation
NCT06838806 ·Status: RECRUITING
-
Development and Application of Molecular Evaluation Instrument for Lung Cancer Diagnosis and Treatment
NCT06086587 ·Status: NOT_YET_RECRUITING
-
Novel Detection System for Lung Cancer Curative Effect Monitoring
NCT02666755 ·Status: UNKNOWN
-
Prognostic Value of Lung Cancer MicroAnatomy in 3D
NCT05565677 ·Status: UNKNOWN
-
Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients
NCT07012759 ·Status: RECRUITING
-
Comparision of Various Biomarkers Between Peripheral and Pulmonary Blood
NCT05587114 ·Status: RECRUITING
-
Perioperative and Postoperative Circulating Tumor Cell Monitoring in Different Stage of NSCLC
NCT07186855 ·Status: COMPLETED
-
Biomarkers in Tissue and Blood Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01139944 ·Status: COMPLETED
-
Lung Cancer Diagnosis and Staging Using Ultrasound Guidance
NCT01623765 ·Status: COMPLETED
-
The Prognostic and Predictive Value of the CA-125 Marker in Lung Cancer Monitoring
NCT02437760 ·Status: UNKNOWN
-
A Comprehensive Evaluation of Circulating Tumor DNA and Circulating Tumor Cells as a Predictive Marker in Lung Cancer
NCT04254497 ·Status: COMPLETED
-
Monitoring the Changes of Tumor-related Biomarkers Before and After Pulmonary Nodule Biopsy.
NCT03397355 ·Status: UNKNOWN
-
Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease
NCT01450553 ·Status: UNKNOWN